Results 161 to 170 of about 187,751 (309)

Research on the innovation of medical expenses protection mechanism for rare disease patients in China. [PDF]

Front Public Health
Song M, Li Y.
europepmc   +1 more source

Economic evaluations of antiobesity medications: A systematic literature review

British Journal of Clinical Pharmacology, EarlyView.
The global prevalence of obesity is rising rapidly. With several antiobesity medications approved and many more in development, understanding their economic value is increasingly important. This study reviews full economic evaluations of approved antiobesity medications to assess cost‐effectiveness and inform reimbursement and access decisions.
Martina Jurković, Almir Fajkić, Andrea Katrin Faour, Mirna Momčilović, Petra Turčić, Andrej Belančić   +5 more
wiley   +1 more source

Traditional Chinese medicine reimbursement reform in China: implementation progress, policy constraints, and optimization strategies. [PDF]

Front Public Health
Zhao F, Chen Y, Tong X.
europepmc   +1 more source

Towards appropriate guidance for the ethical challenges of environmentally sustainable prescribing

British Journal of Clinical Pharmacology, EarlyView.
The environmental impact of medicines poses a significant threat to planetary and public health, making it essential to integrate environmental sustainability into prescribing practices. While the most effective measures to reduce environmental impact, such as reducing unnecessary prescriptions and medication waste, are consistent with appropriate ...
Joost D. Piët, Steven R. Kraaijeveld, Erik M. Donker, Milan C. Richir, Caroline T. A. Moermond, Amy Booth, SanYuMay Tun, Thijs H. Oude Munnink, Patricia M. L. A. van den Bemt, Lorena Dima, Ben J. A. Janssen, Mathilde Jalving, Tomás Mauro van Emden, Fabrizio de Ponti, Robert Likic, João Costa, Marc Labriffe, Charlotte L. Bekker, Carlotta Lunghi, Elisabetta Poluzzi, Michiel A. van Agtmael, Yolande Voskes, Jelle Tichelaar   +22 more
wiley   +1 more source

Proposing a Coverage With Evidence Development Framework for Accelerated Approval at the U.S. Food and Drug Administration. [PDF]

Pharmacoepidemiol Drug Saf
Bearelly D, Desai P, Zhu DT, Balkrishnan R.   +3 more
europepmc   +1 more source

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

Biotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga, Udisha Singh, Sachin Dattram Pawar   +2 more
wiley   +1 more source

Economic Factors Associated with AI Adoption in Oncology: Cost-Effectiveness Perceptions, Reimbursement Readiness, and Return-on-Investment Confidence Among Romanian Healthcare Professionals. [PDF]

Healthcare (Basel)
Negoiță DC, Stanga L, Branea HS, Roșca CI, Ilie AC, Rosca O.   +5 more
europepmc   +1 more source

Life-Course Access to Speech and Language Therapy: A Rights-Based AAAQ Policy Mapping in Türkiye and Four Comparator Settings. [PDF]

Int J Lang Commun Disord
Ayas H, Çiyiltepe MM.
europepmc   +1 more source

From Awareness to Action: Consumer Behaviour, Attitudes and Business Strategy in Sustainable and Circular Electronic Devices

Business Strategy and the Environment, EarlyView.
ABSTRACT Technological change and the increasing use of electronic devices have made electronic waste one of the fastest‐growing waste streams worldwide, posing significant environmental and social challenges. Thus, understanding consumer behaviour regarding the purchase, use and disposal of electronic products is key to developing effective circular ...
Idiano D'Adamo, Steven De Meester, Simone Di Leo, Massimo Gastaldi, Domiziana Lunadei   +4 more
wiley   +1 more source

Regulatory reform and adult methylphenidate dispensing in France: a nationwide interrupted time-series study. [PDF]

BMJ Ment Health
Saint-Dizier C, Therribout N, Carton L, Icick R, Mercier P, Caron C, Bubrovszky M, Hamroun A, Génin M, Lamer A.   +9 more
europepmc   +1 more source